163 related articles for article (PubMed ID: 8974558)
1. [The detection of circadian fluctuations in the efficacy of pharmacotherapy in patients with ischemic heart disease using cardiointervalography].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1996; 59(2):24-6. PubMed ID: 8974558
[TBL] [Abstract][Full Text] [Related]
2. [The chronobiological aspects of drug resistance to antianginal therapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1994; 57(4):33-5. PubMed ID: 7950781
[TBL] [Abstract][Full Text] [Related]
3. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
[TBL] [Abstract][Full Text] [Related]
4. [Drugs acting on the heart in therapy of silent myocardial ischemia].
Motz W; Scheler S; Strauer BE
Internist (Berl); 1992 Oct; 33(10):695-700. PubMed ID: 1358855
[No Abstract] [Full Text] [Related]
5. Effects of nifedipine retard on heart rate and autonomic balance in patients with ischemic heart disease.
Sato H; Arai H; Fukuda E; Tsutsumi Y; Yamamoto M; Aizawa T; Long-Tai FL
Int J Clin Pharmacol Res; 2001; 21(2):65-71. PubMed ID: 11824649
[TBL] [Abstract][Full Text] [Related]
6. [Changes in indicators of the antioxidant defense system in patients with ischemic heart disease treated conventionally].
Syrkin AL; Barsel' VA; Alliluev IG; Kogan IG; Aksiutina MS; Eliubaeva ID; Nesmeianova MA; Drozdov DV
Klin Med (Mosk); 1996; 74(3):24-7. PubMed ID: 8926695
[TBL] [Abstract][Full Text] [Related]
7. [The effect of damage to the hypothalamic suprachiasmatic nuclei in rats on the restructuring of the dynamic indices of the cardiointervalogram induced by propranolol].
Arushanian EB; Beĭer EV; Popov AV
Eksp Klin Farmakol; 1995; 58(4):29-32. PubMed ID: 7580748
[TBL] [Abstract][Full Text] [Related]
8. Circadian variation of onset of ischemic heart disease.
Jafri SM; Goldstein S
Adv Intern Med; 1993; 38():107-22. PubMed ID: 8094934
[No Abstract] [Full Text] [Related]
9. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Blagova OV; Nedostup AV
Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
[TBL] [Abstract][Full Text] [Related]
10. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
11. [An evaluation of the efficacy of treating IHD patients with calcium antagonists].
Mordovin VF; Triss SV; Fedorova NA; Chernov VI; Krylov A; Pavliukova EN; Karpov RS
Ter Arkh; 1995; 67(6):5-8. PubMed ID: 7667781
[No Abstract] [Full Text] [Related]
12. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
[TBL] [Abstract][Full Text] [Related]
13. [Daily fluctuations of cardiac rhythm in patients with ischemic heart disease].
Shamliian TA; Arushanian EB
Fiziol Cheloveka; 1994; 20(1):161-4. PubMed ID: 8163082
[No Abstract] [Full Text] [Related]
14. [Evidence-based pharmacological therapy of ischemic heart disease: with reference to the long-term prognosis].
Ishikawa K
J Cardiol; 1998 Feb; 31(2):115-23. PubMed ID: 9513039
[TBL] [Abstract][Full Text] [Related]
15. [Heart rate control: f-channel blockers].
Kryzhanovskiĭ SA; Vititnova MB
Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
[No Abstract] [Full Text] [Related]
16. [Consequences of circadian variability for the treatment of ischemic heart disease].
Herren T; Urban P; Rutishauser W
Schweiz Rundsch Med Prax; 1992 Feb; 81(7):176-82. PubMed ID: 1535952
[TBL] [Abstract][Full Text] [Related]
17. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
[No Abstract] [Full Text] [Related]
18. Chronobiology and chronotherapy of ischemic heart disease.
Portaluppi F; Lemmer B
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):952-65. PubMed ID: 17675179
[TBL] [Abstract][Full Text] [Related]
19. [Ischemic heart disease in the elderly and senile patients: clinical presentation, diagnosis, treatment, prevention].
Martynov AI; Ostroumova OD; Sharif SF
Klin Med (Mosk); 1998; 76(1):5-10. PubMed ID: 9532905
[No Abstract] [Full Text] [Related]
20. Circadian variation of the total ischemic burden and influence by beta-blocking agents.
Fox KM; Mulcahy DA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S100-4. PubMed ID: 11527111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
